Innovative new treatments for inflammatory bowel diseases (IBD) are now being offered in clinical research trials at Virginia Mason supported by BRI.
This blog hopes to bring more awareness and understanding of autoimmune disease, which is so common, yet often so misunderstood.
Adam Lacy-Hulbert, PhD, bring new expertise in Inflamatory Bowel Disease (IBD) and the basic functioning of the immune system.
© 2021 Benaroya Research Institute at Virginia Mason. 1201 Ninth Avenue, Seattle, WA 98101-2795